Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Bone Density Conservation Agents"" wg kryterium: Temat


Tytuł:
Teriparatide and clodronate combination as a potential treatment for complex regional pain syndrome type I in delayed consolidation after foot surgery: a case report and review of the literature.
Autorzy:
Di Sacco F; Department of Orthopedics and Trauma Surgery, University of Pisa, Pisa, Italy. .
Antognetti D; Section of Neurorehabilitation, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Ciapini G; Department of Orthopedics and Trauma Surgery, University of Pisa, Pisa, Italy.
Nicastro M; Department of Anaesthesia and Critical Care Medicine, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy.
Scaglione M; Department of Orthopedics and Trauma Surgery, University of Pisa, Pisa, Italy.
Bottai V; Department of Orthopedics and Trauma Surgery, University of Pisa, Pisa, Italy.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2024 Mar 08; Vol. 18 (1), pp. 142. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Bone Density Conservation Agents*/therapeutic use
Complex Regional Pain Syndromes*/drug therapy
Male ; Humans ; Adult ; Teriparatide/therapeutic use ; Clodronic Acid ; Pain/drug therapy
Czasopismo naukowe
Tytuł:
Treatment of Medication-Related Osteonecrosis of the Jaws without Segmental Resections: A Case Series.
Autorzy:
Fernandes TL; Department of Dentistry, State University of Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil.
Viezzer Fernandes B; Department of Dentistry, State University of Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil.
Franco GCN; Department of Dentistry, State University of Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2024 Feb 26; Vol. 25, pp. e942980. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Bisphosphonate-Associated Osteonecrosis of the Jaw*/surgery
Bisphosphonate-Associated Osteonecrosis of the Jaw*/etiology
Osteoporosis*/chemically induced
Osteoporosis*/complications
Osteoporosis*/drug therapy
Humans ; Female ; Aged ; Diphosphonates/adverse effects ; Neoplasm Recurrence, Local/complications ; Jaw
Czasopismo naukowe
Tytuł:
High Frequencies of Genetic Variants in Patients with Atypical Femoral Fractures.
Autorzy:
Del Real Á; Departamento de Medicina y Psiquiatría, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Facultad de Medicina, Universidad de Cantabria, 39011 Santander, Spain.
Cruz R; Grupo de Medicina Xenómica, Centro de Investigación en Medicina Molecular y Enfermedades Crónicas, Universidade de Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain.
Sañudo C; Departamento de Medicina y Psiquiatría, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Facultad de Medicina, Universidad de Cantabria, 39011 Santander, Spain.
Pérez-Castrillón JL; Internal Medicine Department, University Hospital Rio Hortega of Valladolid, 47012 Valladolid, Spain.
Pérez-Núñez MI; Traumatology Department, University Hospital M. Valdecilla, 39008 Santander, Spain.
Olmos JM; Departamento de Medicina y Psiquiatría, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Facultad de Medicina, Universidad de Cantabria, 39011 Santander, Spain.; Internal Medicine Department, Marqués de Valdecilla University Hospital, 39008 Santander, Spain.
Hernández JL; Departamento de Medicina y Psiquiatría, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Facultad de Medicina, Universidad de Cantabria, 39011 Santander, Spain.; Internal Medicine Department, Marqués de Valdecilla University Hospital, 39008 Santander, Spain.
García-Ibarbia C; Internal Medicine Department, Marqués de Valdecilla University Hospital, 39008 Santander, Spain.
Valero C; Departamento de Medicina y Psiquiatría, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Facultad de Medicina, Universidad de Cantabria, 39011 Santander, Spain.; Internal Medicine Department, Marqués de Valdecilla University Hospital, 39008 Santander, Spain.
Riancho JA; Departamento de Medicina y Psiquiatría, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Facultad de Medicina, Universidad de Cantabria, 39011 Santander, Spain.; Internal Medicine Department, Marqués de Valdecilla University Hospital, 39008 Santander, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 15; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Femoral Fractures*/genetics
Bone Diseases*
Bone Density Conservation Agents*
Humans ; Femur/pathology ; Diaphyses ; Diphosphonates
Czasopismo naukowe
Tytuł:
Denosumab-induced hypocalcemia in patients with solid tumors and renal dysfunction: a multicenter, retrospective, observational study.
Autorzy:
Nakamura K; Shizuoka General Hospital, -27-1, Kita-ando, Aoi-ku, 420-8527, Shizuoka, Japan. .
Kaya M; Shizuoka General Hospital, -27-1, Kita-ando, Aoi-ku, 420-8527, Shizuoka, Japan.
Yanagisawa Y; Shizuoka Cancer Center, Nagaizumi, Japan.
Yamamoto K; Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Takayashiki N; Iwata City Hospital, Shizuoka, Japan.
Ukita H; Iwata City Hospital, Shizuoka, Japan.
Nagura M; Chutoen General Medical Center, Kakegawa, Japan.
Sugiue K; Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan.
Kitajima M; Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
Hirano K; Hamamatsu Medical Center, Hamamatsu, Japan.
Ishida H; JA Shizuoka Kohseiren Enshu Hospital, Hamamatsu, Japan.
Onoda C; Yaizu City Hospital, Yaizu, Japan.
Kobayashi Y; Fujinomiya City General Hospital, Fujinomiya, Japan.
Nakatani E; Shizuoka Graduate University of Public Health, Shizuoka, Japan.
Odagiri K; Center for Clinical Research, Hamamatsu University Hospital, Hamamatsu, Japan.
Suzuki T; Shizuoka General Hospital, -27-1, Kita-ando, Aoi-ku, 420-8527, Shizuoka, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 15; Vol. 24 (1), pp. 218. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
Hypocalcemia*/chemically induced
Hypocalcemia*/prevention & control
Bone Density Conservation Agents*/adverse effects
Bone Neoplasms*/drug therapy
Kidney Diseases*/chemically induced
Male ; Humans ; Middle Aged ; Aged ; Aged, 80 and over ; Denosumab/adverse effects ; Calcium/adverse effects ; Retrospective Studies ; Albumins/adverse effects
Czasopismo naukowe
Tytuł:
Analyzing the factors associated with efficacy among teriparatide treatment in postmenopausal women with osteoporosis.
Autorzy:
Kong M; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Gao C; Department of Oncology, Qingdao Municipal Hospital, No. 1, Jiao Zhou Road, Qing'dao, 266000, Shandong Province, China.
Luan X; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Fan C; Department of General Surgery, Ankang Hospital of Shandong Province, No. 1, Ji Dai Road, Ji'ning, 272000, Shandong Province, China.
Hao M; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Jin C; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Zhao J; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Li H; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Zhao J; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Luan J; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China.
Lin Y; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China. .
Li Q; Department of Spine Surgery, Qingdao Municipal Hospital, No. 5, Middle Dong Hai Road, Qing'dao, 266000, Shandong Province, China. .
Pokaż więcej
Źródło:
BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2024 Feb 03; Vol. 25 (1), pp. 109. Date of Electronic Publication: 2024 Feb 03.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*
Osteoporosis*/diagnostic imaging
Osteoporosis*/drug therapy
Gastrointestinal Diseases*
Osteoporosis, Postmenopausal*/diagnostic imaging
Osteoporosis, Postmenopausal*/drug therapy
Humans ; Female ; Teriparatide/therapeutic use ; Teriparatide/pharmacology ; Retrospective Studies ; Postmenopause ; Glucocorticoids/therapeutic use ; Bone Density ; Diphosphonates/therapeutic use ; Lumbar Vertebrae/diagnostic imaging
Czasopismo naukowe
Tytuł:
Highlights on the Effects of Non-Coding RNAs in the Osteonecrosis of the Jaw.
Autorzy:
Caserta S; Hematology Unit, Department of Human Pathology in Adulthood and Childhood 'Gaetano Barresi', University of Messina, Via Consolare Valeria, 98125 Messina, Italy.
Stagno F; Hematology Unit, Department of Human Pathology in Adulthood and Childhood 'Gaetano Barresi', University of Messina, Via Consolare Valeria, 98125 Messina, Italy.
Gangemi S; Allergy and Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 98125 Messina, Italy.
Allegra A; Hematology Unit, Department of Human Pathology in Adulthood and Childhood 'Gaetano Barresi', University of Messina, Via Consolare Valeria, 98125 Messina, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 27; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Osteonecrosis*/metabolism
Bone Density Conservation Agents*
Multiple Myeloma*
MicroRNAs*/genetics
Humans ; Diphosphonates
Czasopismo naukowe
Tytuł:
Physicians' awareness of medication-related osteonecrosis of the jaw in patients with osteoporosis.
Autorzy:
Supanumpar N; Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Chulalongkorn University, Bangkok, Thailand.
Pisarnturakit PP; Faculty of Dentistry, Department of Community Dentistry, Chulalongkorn University, Bangkok, Thailand.
Charatcharoenwitthaya N; Department of Medicine, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.
Subbalekha K; Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Chulalongkorn University, Bangkok, Thailand.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 26; Vol. 19 (1), pp. e0297500. Date of Electronic Publication: 2024 Jan 26 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Bisphosphonate-Associated Osteonecrosis of the Jaw*/epidemiology
Bisphosphonate-Associated Osteonecrosis of the Jaw*/etiology
Bisphosphonate-Associated Osteonecrosis of the Jaw*/diagnosis
Osteoporosis*/complications
Physicians*
Humans ; Cross-Sectional Studies ; Diphosphonates/therapeutic use
Czasopismo naukowe
Tytuł:
A pilot feasibility randomised controlled trial of bone antiresorptive agents on bone turnover markers in critically ill women.
Autorzy:
Orford NR; Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Australia. .; Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine (SPPHPM), Monash University, Melbourne, Australia. .; IMPACT-Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia. .; Department of Critical Care, University of Melbourne, Melbourne, Australia. .
Bone A; Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Australia.; Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine (SPPHPM), Monash University, Melbourne, Australia.
Kotowicz MA; IMPACT-Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.; Department of Medicine-Western Health, The University of Melbourne, Melbourne, Australia.
Bailey M; Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine (SPPHPM), Monash University, Melbourne, Australia.
Pasco JA; IMPACT-Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.; Department of Medicine-Western Health, The University of Melbourne, Melbourne, Australia.
Maiden M; Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Australia.
Kakho N; Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Australia.
Cattigan C; Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Australia.
Nichonghaile M; Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Australia.
Jones C; Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Australia.
Hodgson C; Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine (SPPHPM), Monash University, Melbourne, Australia.
Nair P; Intensive Care Unit, St Vincent's Hospital Sydney, Sydney, Australia.; Garvan Institute of Medical Research, Sydney, Australia.
Center J; Intensive Care Unit, St Vincent's Hospital Sydney, Sydney, Australia.; Garvan Institute of Medical Research, Sydney, Australia.
Bellomo R; Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine (SPPHPM), Monash University, Melbourne, Australia.; Department of Critical Care, University of Melbourne, Melbourne, Australia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 24; Vol. 14 (1), pp. 2071. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Bone Density Conservation Agents*/therapeutic use
Humans ; Female ; Critical Illness ; Denosumab ; Feasibility Studies ; Pandemics ; Bone Remodeling
Czasopismo naukowe
Tytuł:
Cost-consequence analysis of continuous denosumab therapy for osteoporosis treatment in South Korea.
Autorzy:
Cha S; NDnex, Saebitgongwon-ro 67, Gwangmyeong-si, Gyeonggi-do, 14348, Republic of Korea.
Sohn M; Amgen Korea Ltd, Seoul, Republic of Korea.
Yang H; Amgen Korea Ltd, Seoul, Republic of Korea.
Yeh EJ; Amgen Inc, Thousand Oaks, CA, USA.
Baek KH; Internal Medicine, Yeouido St.Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Ha J; Internal Medicine, Seoul St.Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Ku H; NDnex, Saebitgongwon-ro 67, Gwangmyeong-si, Gyeonggi-do, 14348, Republic of Korea. .
Pokaż więcej
Źródło:
BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2024 Jan 20; Vol. 25 (1), pp. 76. Date of Electronic Publication: 2024 Jan 20.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*
Osteoporosis*/drug therapy
Osteoporosis*/chemically induced
Fractures, Bone*/drug therapy
Osteoporosis, Postmenopausal*/drug therapy
Humans ; Female ; Denosumab/therapeutic use ; Health Care Costs
Czasopismo naukowe
Tytuł:
Atypical femur fracture in a male without history of bisphosphonate use: a case report.
Autorzy:
Al-Ajlouni YA; School of Medicine, New York Medical College, Valhalla, NY, 10595, USA. yal_.
Lee JL; School of Medicine, New York Medical College, Valhalla, NY, 10595, USA.
Lee JL; School of Medicine, New York Medical College, Valhalla, NY, 10595, USA.
Samuels B; School of Medicine, New York Medical College, Valhalla, NY, 10595, USA.; Westchester Medical Center, Valhalla, NY, 10595, USA.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2024 Jan 04; Vol. 18 (1), pp. 2. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Bone Density Conservation Agents*/therapeutic use
Femoral Fractures*/chemically induced
Femoral Fractures*/diagnostic imaging
Femoral Fractures*/surgery
Male ; Humans ; Aged ; Diphosphonates/adverse effects ; Teriparatide/therapeutic use ; Femur
Czasopismo naukowe
Tytuł:
Multifunctional gold nanoparticles for osteoporosis: synthesis, mechanism and therapeutic applications.
Autorzy:
Gao W; Division of Joint Surgery and Sports Medicine, Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.; Department of Orthopedics, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.
Liang C; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhao K; Department of Orthopaedics, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Hou M; Department of Orthopedics, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China. .
Wen Y; Division of Joint Surgery and Sports Medicine, Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 Dec 07; Vol. 21 (1), pp. 889. Date of Electronic Publication: 2023 Dec 07.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Bone Density Conservation Agents*/pharmacology
Bone Density Conservation Agents*/therapeutic use
Metal Nanoparticles*/therapeutic use
Osteoporosis*/drug therapy
Humans ; Gold/therapeutic use ; Teriparatide/therapeutic use
Czasopismo naukowe
Tytuł:
Effect of denosumab on glucose metabolism in postmenopausal osteoporotic women with prediabetes: a study protocol for a 12-month multicenter, open-label, randomized controlled trial.
Autorzy:
Wang Y; Medical School of Chinese PLA, Beijing, 100853, China.; Department of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.
Jiang Y; Medical School of Chinese PLA, Beijing, 100853, China.; Department of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.
Li J; Department of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.; National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation, Beijing, 100853, China.
Lin X; Medical School of Chinese PLA, Beijing, 100853, China.; Department of Rehabilitation, the Second Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Luo Y; Department of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.; National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation, Beijing, 100853, China.
Tan S; Medical School of Chinese PLA, Beijing, 100853, China.; Department of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.
Yang H; Medical School of Chinese PLA, Beijing, 100853, China.; Department of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.
Gao Z; Medical School of Chinese PLA, Beijing, 100853, China.; Department of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.
Cui X; Department of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.; National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation, Beijing, 100853, China.
Yin P; Department of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.; National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation, Beijing, 100853, China.
Kong D; Department of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.
Gao Y; Department of Nursing, the First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Cheng Y; Department of Endocrinology, Chinese PLA General Hospital, Beijing, 100853, China.
Zhang L; Department of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.; National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation, Beijing, 100853, China.
Tang P; Department of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China. .; National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation, Beijing, 100853, China. .
Lyu H; Department of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China. .; National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation, Beijing, 100853, China. .
Pokaż więcej
Źródło:
Trials [Trials] 2023 Dec 18; Vol. 24 (1), pp. 812. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Bone Density Conservation Agents*/pharmacology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Osteoporosis*/diagnosis
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*/diagnosis
Osteoporosis, Postmenopausal*/drug therapy
Prediabetic State*/diagnosis
Prediabetic State*/drug therapy
Female ; Humans ; Blood Glucose ; Bone Density ; Denosumab/pharmacology ; Glycated Hemoglobin ; Multicenter Studies as Topic ; Postmenopause ; Randomized Controlled Trials as Topic ; RANK Ligand
Czasopismo naukowe
Tytuł:
A Case Report of Oral Bisphosphonate Treatment for Osteoporosis Leading to Atypical Femoral Fracture and Pathologic Mandibular Fracture.
Autorzy:
Fernandes TL; Postgraduate Program in Dentistry, State University of Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil.; Unimed General Hospital, Ponta Grossa, PR, Brazil.
Viezzer Fernandes B; Postgraduate Program in Dentistry, State University of Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil.; Unimed General Hospital, Ponta Grossa, PR, Brazil.
Jitumori C; Unimed General Hospital, Ponta Grossa, PR, Brazil.; School of Dentistry, Centro de Ensino Superior dos Campos Gerais (CESCAGE), Ponta Grossa, PR, Brazil.
Franco GCN; Postgraduate Program in Dentistry, State University of Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2023 Oct 23; Vol. 24, pp. e941144. Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Osteoporosis, Postmenopausal*/complications
Osteoporosis, Postmenopausal*/drug therapy
Osteoporosis, Postmenopausal*/chemically induced
Bone Density Conservation Agents*/adverse effects
Mandibular Fractures*/surgery
Mandibular Fractures*/chemically induced
Mandibular Fractures*/drug therapy
Osteoporosis*/chemically induced
Osteoporosis*/drug therapy
Fractures, Spontaneous*/chemically induced
Fractures, Spontaneous*/diagnostic imaging
Femoral Fractures*/chemically induced
Femoral Fractures*/surgery
Osteomyelitis*/drug therapy
Female ; Humans ; Middle Aged ; Diphosphonates/adverse effects ; Alendronate/adverse effects
Czasopismo naukowe
Tytuł:
Conversion in a Resectable Tumor after Denosumab Neoadjuvant in a Large Dorsal Giant Cells Tumor: A Case Report and a Literature Review.
Autorzy:
Sereno M; Medical Oncology Department, Infanta Sofía University Hospital, Europe Avenue 32, San Sebastián de los Reyes, 28702 Madrid, Spain.; European University of Madrid, Medicine Departtment, Calle Tajo 1, Villaviciosa de Odón, 28745 Madrid, Spain.; FIIB HUIS HHEN, 28703 Madrid, Spain.; Precision Nutrition and Cancer Program, Clinical Oncology Group, IMDEA Food Institute, CEI UAM, CSIC, 28049 Madrid, Spain.
Franco SR; Medical Oncology Department, Infanta Sofía University Hospital, Europe Avenue 32, San Sebastián de los Reyes, 28702 Madrid, Spain.; FIIB HUIS HHEN, 28703 Madrid, Spain.; Precision Nutrition and Cancer Program, Clinical Oncology Group, IMDEA Food Institute, CEI UAM, CSIC, 28049 Madrid, Spain.
de la Reina L; Neurosurgeon, Neurosurgery Department, Puerta de Hierro University Hospital, C. Joaquín Rodrigo, 1, Majadahonda, 28222 Madrid, Spain.
Campo-Cañaveral de la Cruz JL; European University of Madrid, Medicine Departtment, Calle Tajo 1, Villaviciosa de Odón, 28745 Madrid, Spain.; Thoracic Surgery Department, Puerta de Hierro University Hospital, C. Joaquín Rodrigo, 1, Majadahonda, 28222 Madrid, Spain.
Muñoz de Legaría M; Neurosurgeon, Neurosurgery Department, Puerta de Hierro University Hospital, C. Joaquín Rodrigo, 1, Majadahonda, 28222 Madrid, Spain.; Pathology Department, Infanta Sofía University Hospital, Europe Avenue 32, San Sebastián de los Reyes, 28702 Madrid, Spain.
Casado Saénz E; Medical Oncology Department, Infanta Sofía University Hospital, Europe Avenue 32, San Sebastián de los Reyes, 28702 Madrid, Spain.; European University of Madrid, Medicine Departtment, Calle Tajo 1, Villaviciosa de Odón, 28745 Madrid, Spain.; FIIB HUIS HHEN, 28703 Madrid, Spain.; Precision Nutrition and Cancer Program, Clinical Oncology Group, IMDEA Food Institute, CEI UAM, CSIC, 28049 Madrid, Spain.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Oct 21; Vol. 30 (10), pp. 9335-9345. Date of Electronic Publication: 2023 Oct 21.
Typ publikacji:
Review; Case Reports
MeSH Terms:
Bone Density Conservation Agents*/therapeutic use
Giant Cell Tumor of Bone*/drug therapy
Giant Cell Tumor of Bone*/surgery
Spinal Neoplasms*/drug therapy
Spinal Neoplasms*/pathology
Humans ; Denosumab/therapeutic use ; Neoadjuvant Therapy ; Giant Cells/pathology
Recenzja
Tytuł:
Denosumab administration for bone metastases from solid tumors: a retrospective cross-sectional study.
Autorzy:
Mizuta K; Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Okinawa, Japan.
Oshiro H; Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Okinawa, Japan.
Katsuki R; Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Okinawa, Japan.
Tsuha Y; Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Okinawa, Japan.
Aoki Y; Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Okinawa, Japan.
Tome Y; Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Okinawa, Japan. .
Nishida K; Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Okinawa, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Oct 18; Vol. 23 (1), pp. 999. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Neoplasms*/drug therapy
Bone Neoplasms*/secondary
Bone Density Conservation Agents*/therapeutic use
Adult ; Humans ; Aged ; Adolescent ; Denosumab/therapeutic use ; Cross-Sectional Studies ; Diphosphonates ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Clinicians' views of prescribing oral and intravenous bisphosphonates for osteoporosis: a qualitative study.
Autorzy:
Bishop S; Nottingham University Business School, University of Nottingham, Nottingham, NG5 1PB, UK. .
Narayanasamy MJ; School of Medicine, University of Nottingham, QMC Campus, Nottingham, NG7 2UH, UK.
Paskins Z; School of Medicine, Keele University, David Weatherall Building, Newcastle-Under-Lyme, UK.; ST5 5BG and Haywood Academic Rheumatology Centre, Haywood Hospital, High Lane, Burslem, Stoke-On-Trent, ST6 7AG, UK.
Corp N; School of Primary, Community and Social Care, Keele University, Newcastle-Under-Lyme, ST5 5BG, UK.
Bastounis A; Division of Epidemiology & Public Health, School of Medicine, University of Nottingham, City Hospital, Nottingham, NG5 1PB, UK.
Griffin J; Royal Osteoporosis Society (ROS), St James House, The Square, Lower Bristol Road, Bath, BA2 3BH, UK.
Gittoes N; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
Leonardi-Bee J; Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham, NG5 1PB, UK.
Langley T; Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham, NG5 1PB, UK.
Sahota O; Department of Healthcare of Older People, Nottingham University Hospitals NHS Trust, Nottingham, NG72UH, UK.
Pokaż więcej
Źródło:
BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2023 Sep 29; Vol. 24 (1), pp. 770. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:
Journal Article
MeSH Terms:
Osteoporosis*/drug therapy
Osteoporosis*/chemically induced
Bone Density Conservation Agents*
Osteoporosis, Postmenopausal*/drug therapy
Humans ; Female ; Zoledronic Acid/therapeutic use ; Diphosphonates/adverse effects ; Ibandronic Acid/therapeutic use ; Alendronate/therapeutic use
Czasopismo naukowe
Tytuł:
Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.
Autorzy:
Park H; Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
Ryu HJ; Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 115 Irwon-Ro, Gangnam-Gu, Seoul, 06355, Korea.
Heo J; Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju-si, Gangwon-do, Korea.
Chung MK; Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Son YI; Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim JH; Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Korea.
Hahn SY; Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Shin JH; Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Oh YL; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim SW; Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 115 Irwon-Ro, Gangnam-Gu, Seoul, 06355, Korea.
Chung JH; Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 115 Irwon-Ro, Gangnam-Gu, Seoul, 06355, Korea.
Kim JS; Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Korea. .
Kim TH; Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 115 Irwon-Ro, Gangnam-Gu, Seoul, 06355, Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 20; Vol. 13 (1), pp. 15663. Date of Electronic Publication: 2023 Sep 20.
Typ publikacji:
Journal Article
MeSH Terms:
Thyroid Neoplasms*/surgery
Bone Density Conservation Agents*
Humans ; Calcitonin ; Thyroidectomy ; Retrospective Studies ; Calcium-Regulating Hormones and Agents
SCR Disease Name:
Thyroid cancer, medullary
Czasopismo naukowe
Tytuł:
Identification of a novel Sorcin isoform with a different C-terminal but intact dimerization property.
Autorzy:
Tanwar S; Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110062, India.
Qais FA; Department of Agricultural Microbiology, Faculty of Agricultural Sciences, Aligarh Muslim University, Aligarh, UP, 202002, India.
Naaz F; Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110062, India.
Rashid N; Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110062, India.
Ahmad F; Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110062, India.
Ur Rehman S; Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110062, India. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 14; Vol. 13 (1), pp. 15262. Date of Electronic Publication: 2023 Sep 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Calcium*
Bone Density Conservation Agents*
Animals ; Mice ; Dimerization ; Molecular Docking Simulation ; Protein Isoforms/genetics ; Mammals
Czasopismo naukowe
Tytuł:
A real-world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab.
Autorzy:
Bracchi P; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Zecca E; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Brunelli C; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Miceli R; Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Tinè G; Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Maniezzo M; Odontostomatology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Lo Dico S; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Caputo M; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Shkodra M; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Caraceni AT; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (17), pp. 18317-18326. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Observational Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Bisphosphonate-Associated Osteonecrosis of the Jaw*/epidemiology
Bisphosphonate-Associated Osteonecrosis of the Jaw*/etiology
Bone Neoplasms*/secondary
Male ; Middle Aged ; Humans ; Denosumab/adverse effects ; Prevalence ; Diphosphonates ; Angiogenesis Inhibitors/therapeutic use ; Risk Factors ; Hormones ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Treatment of hypercalcaemia of malignancy in adults.
Autorzy:
Mc Donald D; St Vincent's University Hospital, Dublin, Ireland .
Drake MT; Mayo Clinic, Rochester, USA.
Crowley RK; St Vincent's University Hospital, Dublin, and University College Dublin, Ireland.
Pokaż więcej
Źródło:
Clinical medicine (London, England) [Clin Med (Lond)] 2023 Sep; Vol. 23 (5), pp. 503-507. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Hypercalcemia*/etiology
Hypercalcemia*/therapy
Neoplasms*/complications
Bone Density Conservation Agents*/therapeutic use
Humans ; Adult ; Denosumab/therapeutic use ; Diphosphonates/therapeutic use ; Quality of Life
SCR Disease Name:
Humoral Hypercalcemia Of Malignancy
Czasopismo naukowe
Tytuł:
Glucagon-like Peptide-1 Receptor Activation Reduces Pulmonary Vein Arrhythmogenesis and Regulates Calcium Homeostasis.
Autorzy:
Chan CS; Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.; Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan.
Lin FJ; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.; Department of Biomedical Engineering, National Defense Medical Center, Taipei 11490, Taiwan.
Chen YC; Department of Biomedical Engineering, National Defense Medical Center, Taipei 11490, Taiwan.
Lin YK; Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.; Division of Cardiology, Department of Internal Medicine, Wan-Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.
Higa S; Cardiac Electrophysiology and Pacing Laboratory, Division of Cardiovascular Medicine, Makiminato Central Hospital, Okinawa 9012131, Japan.
Chen SA; Heart Rhythm Center, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan.; Institute of Clinical Medicine and Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei 11217, Taiwan.; Cardiovascular Center, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Chen YJ; Division of Cardiology, Department of Internal Medicine, Wan-Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.; Cardiovascular Research Center, Wan-Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 23; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 23.
Typ publikacji:
Journal Article
MeSH Terms:
Atrial Fibrillation*
Pulmonary Veins*
Bone Density Conservation Agents*
Animals ; Rabbits ; Glucagon-Like Peptide-1 Receptor ; Calcium ; Calcium-Calmodulin-Dependent Protein Kinase Type 2 ; Hormone Antagonists ; Anti-Arrhythmia Agents ; Amides ; Cyclic AMP-Dependent Protein Kinases ; Glucagon-Like Peptide 1/pharmacology ; Homeostasis
Czasopismo naukowe
Tytuł:
Successful Hemodialysis Treatment of Severe Hypercalcemia Following COVID-19 in Multiple Myeloma: A Case Report.
Autorzy:
Goss CH; Department of Internal Medicine, Charleston Area Medical Center, Charleston, WV, USA.
Ezaldin S; Department of Internal Medicine, Charleston Area Medical Center, Charleston, WV, USA.
Aijaz P; Department of Internal Medicine, Charleston Area Medical Center, Charleston, WV, USA.
Anees A; Department of Internal Medicine, Charleston Area Medical Center, Charleston, WV, USA.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2023 Aug 10; Vol. 24, pp. e940835. Date of Electronic Publication: 2023 Aug 10.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hypercalcemia*/etiology
Hypercalcemia*/therapy
Hypercalcemia*/diagnosis
Multiple Myeloma*/complications
Multiple Myeloma*/therapy
COVID-19*/complications
Bone Density Conservation Agents*
Male ; Humans ; Aged ; Calcium ; Renal Dialysis/adverse effects
Czasopismo naukowe
Tytuł:
Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study.
Autorzy:
Sakamoto Y; Department of Dentistry and Oral Surgery, Kansai Medical University Medical Center, 10-15 Fumizono-Cho, Moriguchi, Osaka, 570-8507, Japan. .
Sawada S; Department of Dentistry and Oral Surgery and Oral Care, Kansai Medical University Hospital, Hirakata, Osaka, 573-1191, Japan.
Kojima Y; Department of Dentistry and Oral Surgery and Oral Care, Kansai Medical University Hospital, Hirakata, Osaka, 573-1191, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 09; Vol. 13 (1), pp. 12890. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Bisphosphonate-Associated Osteonecrosis of the Jaw*/diagnostic imaging
Osteolysis*/diagnostic imaging
Osteolysis*/etiology
Bone Density Conservation Agents*/adverse effects
Humans ; Retrospective Studies ; Diphosphonates/adverse effects ; Tomography, X-Ray Computed ; Jaw
Czasopismo naukowe
Tytuł:
Prescription of vitamin D was associated with a lower incidence of hip fractures.
Autorzy:
Yakabe M; Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Hosoi T; Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Matsumoto S; Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Fujimori K; Department of Health Administration and Policy, Tohoku University School of Medicine, 2-1 Seiryo-Machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.; National Database Japan-Osteoporosis Management (NDBJ-OS) Study Group, Kindai University Faculty of Medicine, 377-2 Oono-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Tamaki J; Department of Hygiene and Public Health, Faculty of Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki, Osaka, 569-8686, Japan.; National Database Japan-Osteoporosis Management (NDBJ-OS) Study Group, Kindai University Faculty of Medicine, 377-2 Oono-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Nakatoh S; Department of Orthopedic Surgery, Asahi General Hospital, 477 Tomari, Asahimachi, Shimo-Nikawa-gun, Toyama, 939-0798, Japan.; National Database Japan-Osteoporosis Management (NDBJ-OS) Study Group, Kindai University Faculty of Medicine, 377-2 Oono-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Ishii S; Department of Regulatory Science, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachiouji, Tokyo, 193-0392, Japan.; National Database Japan-Osteoporosis Management (NDBJ-OS) Study Group, Kindai University Faculty of Medicine, 377-2 Oono-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Okimoto N; Okimoto Clinic, 185-4 Kubi, Yutaka-machi, Kure, Hiroshima, 734-0304, Japan.; National Database Japan-Osteoporosis Management (NDBJ-OS) Study Group, Kindai University Faculty of Medicine, 377-2 Oono-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Kamiya K; Department of Hygiene and Public Health, Faculty of Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki, Osaka, 569-8686, Japan.; National Database Japan-Osteoporosis Management (NDBJ-OS) Study Group, Kindai University Faculty of Medicine, 377-2 Oono-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Akishita M; Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Iki M; Kindai University Faculty of Medicine, 377-2 Oono-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.; National Database Japan-Osteoporosis Management (NDBJ-OS) Study Group, Kindai University Faculty of Medicine, 377-2 Oono-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Ogawa S; Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. .; National Database Japan-Osteoporosis Management (NDBJ-OS) Study Group, Kindai University Faculty of Medicine, 377-2 Oono-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 09; Vol. 13 (1), pp. 12889. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bone Density Conservation Agents*/therapeutic use
Osteoporosis*/drug therapy
Osteoporosis*/epidemiology
Osteoporosis*/chemically induced
Hip Fractures*/epidemiology
Hip Fractures*/prevention & control
Hip Fractures*/chemically induced
Humans ; Vitamin D/therapeutic use ; Incidence ; Vitamins/therapeutic use
Czasopismo naukowe
Tytuł:
Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system.
Autorzy:
Xiao Y; Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University, Changsha, 410008, Hunan, China.
Chen Y; Department of Gastroenterology, Xiangya Hospital of Central South University, Changsha, 410008, Hunan, China.
Huang Y; Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University, Changsha, 410008, Hunan, China.
Xiao Y; Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University, Changsha, 410008, Hunan, China. .; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, 410008, Hunan, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jul 05; Vol. 13 (1), pp. 10892. Date of Electronic Publication: 2023 Jul 05.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Osteoporosis*/complications
Humans ; Alendronate/adverse effects ; Risedronic Acid ; Denosumab/adverse effects ; Ibandronic Acid ; Pharmaceutical Preparations ; Pamidronate ; Diphosphonates/adverse effects ; Femur
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies